Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception

Steroids

Volumn 76, Issue 7, 2011, Pages 636-652

  Africander, Donita ^a   Verhoog, Nicolette ^b   Hapgood, Janet P ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Contraception; Gene expression; HRT; Progestins; Steroid receptors

Indexed keywords

ANDROGEN RECEPTOR; DIENOGEST; DROSPIRENONE; ESTROGEN RECEPTOR; GESTAGEN; GESTODENE; GLUCOCORTICOID RECEPTOR; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MINERALOCORTICOID RECEPTOR; NORETHISTERONE; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID RECEPTOR; TRIMEGESTONE;

BINDING AFFINITY; BIOLOGICAL ACTIVITY; DRUG CLASSIFICATION; DRUG RECEPTOR BINDING; GENE TARGETING; HORMONAL CONTRACEPTION; HORMONE STRUCTURE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYPERTENSION; LIBIDO DISORDER; MOOD CHANGE; NONHUMAN; REVIEW; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANIMALS; CONTRACEPTION; GENE EXPRESSION REGULATION; HORMONE REPLACEMENT THERAPY; HUMANS; PROGESTERONE CONGENERS; RECEPTORS, STEROID;

EID: 79956289710     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.03.001     Document Type: Review

References (225)

1. F.Z. Stanczyk All progestins are not created equal Steroids 68 10-13 2003 879 890
2. H.O. Critchley, R.W. Kelly, R.M. Brenner, and D.T. Baird Antiprogestins as a model for progesterone withdrawal Steroids 68 10-13 2003 1061 1068
3. P.M. Kevin, L.S. Eugene, and P.W. Shawn The evolution of progesterone receptor ligands Med Res Rev 27 3 2007 374 400
4. L. Speroff, and P.D. Darney Injectable contraception A clinical guide for contraception 2nd Edition 1996 Williams & Wilkins Baltimore, MD
5. G.A. Greendale, B.A. Reboussin, A. Sie, H.R. Singh, L.K. Olson, and O. Gatewood Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators Ann Intern Med 130 1999 262 269 (Pubitemid 29091853)
6. R.D. Gambrell Jr., F.M. Massey, T.A. Castaneda, and A.W. Boddie Estrogen therapy and breast cancer in postmenopausal women J Am Geriatr Soc 28 6 1980 251 257 (Pubitemid 10118268)
7. H.F. Taitel, and M.E. Kafrissen Norethindrone - a review of therapeutic applications Int J Fertil Menopausal Stud 40 4 1995 207 223
8. H. Kuhl Pharmacokinetics of oestrogens and progestogens Maturitas 12 3 1990 171 197 (Pubitemid 20279929)
9. R. Sitruk-Ware, and A. Nath The use of newer progestins for contraception Contraception 82 5 2010 410 417
10. B. Affandi Injectable contraceptives: a worldwide perspective J Fam Plann Reprod Health Care 28 1 2002 3 4
11. A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, and K.W. Schweppe Classification and pharmacology of progestins Maturitas 46 Suppl. 1 2003 S7 S16
12. B.H. Draper, C. Morroni, M. Hoffman, J. Smit, M. Beksinska, and J. Hapgood Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception Cochrane Database Syst Rev 3 2006 CD005214
13. S. Haider, and P.D. Darney Injectable contraception Clin Obstet Gynecol 50 4 2007 898 906 (Pubitemid 350059286)
14. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 321 333 (Pubitemid 34761611)
15. Mws. collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 9382 2003 419 427
16. C.C. Wang, R.S. McClelland, J. Overbaugh, M. Reilly, D.D. Panteleeff, and K. Mandaliya The effect of hormonal contraception on genital tract shedding of HIV-1 AIDS 18 2 2004 205 209 (Pubitemid 38253442)
17. T. Cundy, R. Ames, A. Horne, J. Clearwater, H. Roberts, and G. Gamble A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate J Clin Endocrinol Metab 88 1 2003 78 81 (Pubitemid 36115146)
18. B. Cromer In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents J Pediatr Adolesc Gynecol 18 3 2005 183 187 (Pubitemid 40828588)
19. A.M. Kaunitz Hormone therapy and breast cancer risk: trumping fear with facts Menopause 13 2 2006 160 163
20. G. Rosano, and M. Fini Comparative cardiovascular effects of different progestins in menopause Int J Fertil Womens Med 46 5 2001 248 256
21. E. Lokkegaard, Z. Jovanovic, B.L. Heitmann, N. Keiding, B. Ottesen, and Y.A. Hundrup Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study Arch Neurol 60 10 2003 1379 1384 (Pubitemid 37248798)
22. M.S. Majumder, M. Mohiduzzaman, and K. Ahmad Immunocompetence of marginally nourished women on hormonal contraceptives Nutr Rep Int 36 6 1987 1285 1290 (Pubitemid 18017294)
23. R. Brunelli, D. Frasca, G. Perrone, C. Pioli, A. Fattorossi, and L. Zichella Hormone replacement therapy affects various immune cell subsets and natural cytotoxicity Gynecol Obstet Invest 41 2 1996 128 131 (Pubitemid 26055565)
24. W.B. Malarkey, M. Burleson, J.T. Cacioppo, K. Poehlmann, R. Glaser, and J.K. Kiecolt-Glaser Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women Endocrine 7 2 1997 227 233 (Pubitemid 28092095)
25. A. Wakatsuki, Y. Okatani, N. Ikenoue, and T. Fukaya Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen Circulation 105 12 2002 1436 1439 (Pubitemid 34263274)
26. T. Ohkura, K. Isse, K. Akazawa, M. Hamamoto, Y. Yaoi, and N. Hagino Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports Dementia 6 2 1995 99 107
27. S.A. Shumaker, C. Legault, S.R. Rapp, L. Thal, R.B. Wallace, and J.K. Ockene Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 2003 2651 2662 (Pubitemid 37430136)
28. M.S. Fernandes, J.J. Brosens, and B. Gellersen Honey, we need to talk about the membrane progestin receptors Steroids 73 9-10 2008 942 952
29. G.A. Colditz Estrogen, estrogen plus progestin therapy, and risk of breast cancer Clin Cancer Res 11 2 Pt 2 2005 909s 917s (Pubitemid 40111105)
30. U. Stopinska-Gluszak, J. Waligora, T. Grzela, M. Gluszak, J. Jozwiak, and D. Radomski Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women J Reprod Immunol 69 1 2006 65 75 (Pubitemid 43144472)
31. B.A. Cromer, D. Scholes, A. Berenson, T. Cundy, M.K. Clark, and A.M. Kaunitz Depot medroxyprogesterone acetate and bone mineral density in adolescents - the Black Box Warning: a Position Paper of the Society for Adolescent Medicine J Adolesc Health 39 2 2006 296 301 (Pubitemid 44062349)
32. R. Sitruk-Ware Progestins and cardiovascular risk markers Steroids 65 10-11 2000 651 658
33. J.L. Turgeon, D.P. McDonnell, K.A. Martin, and P.M. Wise Hormone therapy: physiological complexity belies therapeutic simplicity Science 304 5675 2004 1269 1273 (Pubitemid 38697412)
34. I. Valdivia, I. Campodonico, A. Tapia, M. Capetillo, A. Espinoza, and P. Lavin Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women Fertil Steril 81 3 2004 617 623 (Pubitemid 38376119)
35. I.S. Odmark, T. Backstrom, B. Jonsson, and M. Bixo Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being Gynecol Endocrinol 18 6 2004 305 317 (Pubitemid 38922829)
36. W. Oelkers Drospirenone, a progestogen with antimineralocorticoid properties: a short review Mol Cell Endocrinol 217 1-2 2004 255 261 (Pubitemid 38596651)
37. J.P. Hapgood, D. Koubovec, A. Louw, and D. Africander Not all progestins are the same: implications for usage Trends Pharmacol Sci 25 11 2004 554 557 (Pubitemid 39371144)
38. R. Sitruk-Ware Pharmacological profile of progestins Maturitas 47 2004 277 283 (Pubitemid 38523308)
39. S. Sasagawa, Y. Shimizu, H. Kami, T. Takeuchi, S. Mita, and K. Imada Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile Steroids 73 2 2008 222 231
40. X. Li, D.M. Lonard, and B.W. O'Malley A contemporary understanding of progesterone receptor function Mech Ageing Dev 125 10-11 2004 669 678
41. Y. Ishida, Y. Ishida, and J.N. Heersche Pharmacologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: an hypothesis Osteoporos Int 13 8 2002 601 605
42. Y. Ishida, T. Mine, and T. Taguchi Effect of progestins with different glucocorticoid activity on bone metabolism Clin Endocrinol (Oxf) 68 3 2008 423 428 (Pubitemid 351257862)
43. C.M. Bamberger, T. Else, A.M. Bamberger, F.U. Beil, and H.M. Schulte Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes J Clin Endocrinol Metab 84 11 1999 4055 4061 (Pubitemid 30644194)
44. J. Kurebayashi, T. Otsuki, K. Tanaka, Y. Yamamoto, T. Moriya, and H. Sonoo Medroxyprogesterone acetate decreases secretion of interleukin-6 and parathyroid hormone-related protein in a new anaplastic thyroid cancer cell line, KTC-2 Thyroid 13 3 2003 249 258 (Pubitemid 36459306)
45. D. Koubovec, W.V. Berghe, L. Vermeulen, G. Haegeman, and J.P. Hapgood Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells Mol Cell Endocrinol 221 1-2 2004 75 85 (Pubitemid 38829725)
46. R. Alzamora, L. Michea, and E.T. Marusic Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries Hypertension 35 5 2000 1099 1104 (Pubitemid 30327264)
47. V. Boonyaratanakornkit, and D.P. Edwards Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones Essays Biochem 40 2004 105 120 (Pubitemid 38901168)
48. R. Narayanan, C.C. Coss, M. Yepuru, J.D. Kearbey, D.D. Miller, and J.T. Dalton Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways Mol Endocrinol 22 11 2008 2448 2465
49. J.R. Revollo, and J.A. Cidlowski Mechanisms generating diversity in glucocorticoid receptor signaling Ann N Y Acad Sci 1179 2009 167 178
50. P.D. Darney The androgenicity of progestins Am J Med 98 1A 1995 104S 110S
51. E. LeBlanc, and A. Laws Benefits and risks of third-generation oral contraceptives J Gen Intern Med 14 10 1999 625 632 (Pubitemid 29506148)
52. H. Kuhl Comparative pharmacology of newer progestogens Drugs 51 2 1996 188 215 (Pubitemid 26039155)
53. F.Z. Stanczyk Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception Rev Endocr Metab Disord 3 3 2002 211 224
54. P. Muhn, U. Fuhrmann, K.H. Fritzemeier, R. Krattenmacher, and E. Schillinger Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity Ann N Y Acad Sci 761 1995 311 335
55. R.C. Winneker, D. Bitran, and Z. Zhang The preclinical biology of a new potent and selective progestin: trimegestone Steroids 68 10-13 2003 915 920
56. Mueck AO, Sitruk-Ware R. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids 2011; In Press, doi:10.1016/j.steroids.2011.02.002.
57. J.A. Delyani Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology Kidney Int 57 4 2000 1408 1411 (Pubitemid 30207899)
58. W. Elger, S. Beier, K. Pollow, R. Garfield, S.Q. Shi, and A. Hillisch Conception and pharmacodynamic profile of drospirenone Steroids 68 10-13 2003 891 905
59. Z. Zhang, S.G. Lundeen, Y. Zhu, J.M. Carver, and R.C. Winneker In vitro characterization of trimegestone: a new potent and selective progestin Steroids 65 10-11 2000 637 643
60. D. Philibert, F. Bouchoux, M. Degryse, D. Lecaque, F. Petit, and M. Gaillard The pharmacological profile of a novel norpregnance progestin (trimegestone) Gynecol Endocrinol 13 5 1999 316 326 (Pubitemid 29511938)
61. P. Huang, V. Chandra, and F. Rastinejad Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics Annu Rev Physiol 72 2010 247 272
62. Y. Wan, K.K. Coxe, V.G. Thackray, P.R. Housley, and S.K. Nordeen Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor Mol Endocrinol 15 1 2001 17 31 (Pubitemid 32156038)
63. R.K. Bledsoe, V.G. Montana, T.B. Stanley, C.J. Delves, C.J. Apolito, and D.D. McKee Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition Cell 110 1 2002 93 105 (Pubitemid 34874609)
64. I. McEwan, D. Lavery, K. Fischer, and K. Watt Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors Nucl Recept Signal 5 2007 e001
65. D.N. Lavery, and I.J. McEwan Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations Biochem J 391 3 2005 449 464 (Pubitemid 41634771)
66. A. Griekspoor, W. Zwart, J. Neefjes, and R. Michalides Visualizing the action of steroid hormone receptors in living cells Nucl Recept Signal 5 2007 e003
67. W. Bourguet, P. Germain, and H. Gronemeyer Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications Trends Pharmacol Sci 21 10 2000 381 388
68. Y. Tang, R.H. Getzenberg, B.N. Vietmeier, M.R. Stallcup, M. Eggert, and R. Renkawitz The DNA-binding and {tau}2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal Mol Endocrinol 12 9 1998 1420 1431 (Pubitemid 128496202)
69. M. Beato, and J. Klug Steroid hormone receptors: an update Hum Reprod Update 6 3 2000 225 236 (Pubitemid 30348891)
70. D.M. Tanenbaum, Y. Wang, S.P. Williams, and P.B. Sigler Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains Proc Natl Acad Sci USA 95 11 1998 5998 6003 (Pubitemid 28248953)
71. S. Williams, and P. Sigler Atomic structure of progesterone complexed with its receptor Nature 393 6683 1998 392 396 (Pubitemid 28269716)
72. P. Fuller The steroid receptor superfamily: mechanisms of diversity FASEB J 5 15 1991 3092 3099 (Pubitemid 21892870)
73. R. Evans The steroid and thyroid hormone receptor superfamily Science 240 4854 1988 889 895
74. H. Loosfelt, M. Atger, M. Misrahi, A. Guiochon-Mantel, C. Meriel, and F. Logeat Cloning and sequence analysis of rabbit progesterone-receptor complementary DNA Proc Natl Acad Sci USA 83 23 1986 9045 9049 (Pubitemid 17223533)
75. R.V. Weatherman, R.J. Fletterick, and T.S. Scanlan Nuclear-receptor ligands and ligand-binding domains Annu Rev Biochem 68 1 1999 559 581 (Pubitemid 29449203)
76. W.B. Pratt, and D.O. Toft Steroid receptor interactions with heat shock protein and immunophilin chaperones Endocr Rev 18 3 1997 306 360 (Pubitemid 27246880)
77. S.R. Hammes, and E.R. Levin Extranuclear steroid receptors: nature and actions Endocr Rev 28 7 2007 726 741 (Pubitemid 350294293)
78. J. Zhou, and J.A. Cidlowski The human glucocorticoid receptor: one gene, multiple proteins and diverse responses Steroids 70 5-7 2005 407 417 (Pubitemid 40616039)
79. N.Z. Lu, S.E. Wardell, K.L. Burnstein, D. Defranco, P.J. Fuller, and V. Giguere The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors Pharmacol Rev 58 4 2006 782 797 (Pubitemid 44833746)
80. V. Perissi, and M.G. Rosenfeld Controlling nuclear receptors: the circular logic of cofactor cycles Nat Rev Mol Cell Biol 6 7 2005 542 554 (Pubitemid 40943045)
81. M. Beato Gene regulation by steroid hormones Cell 56 3 1989 335 344 (Pubitemid 19052651)
82. C. Ballare, M. Uhrig, T. Bechtold, E. Sancho, M. Di Domenico, and A. Migliaccio Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells Mol Cell Biol 23 6 2003 1994 2008 (Pubitemid 36278811)
83. O. Kassel, and P. Herrlich Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects Mol Cell Endocrinol 275 1-2 2007 13 29 (Pubitemid 47259283)
84. K. De Bosscher, and G. Haegeman Minireview: latest perspectives on antiinflammatory actions of glucocorticoids Mol Endocrinol 23 3 2009 281 291
85. S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, and G. Andersson Mechanisms of estrogen action Physiol Rev 81 4 2001 1535 1565 (Pubitemid 32951806)
86. K. De Bosscher, W. Vanden Berghe, and G. Haegeman The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression Endocr Rev 24 4 2003 488 522 (Pubitemid 37059110)
87. I.J. McEwan, A.P. Wright, and J.A. Gustafsson Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions Bioessays 19 2 1997 153 160 (Pubitemid 27114964)
88. J.C. Webster, and J.A. Cidlowski Mechanisms of glucocorticoid-receptor- mediated repression of gene expression Trends Endocrinol Metab 10 10 1999 396 402
89. R. Newton Molecular mechanisms of glucocorticoid action: what is important? Thorax 55 7 2000 603 613 (Pubitemid 30398277)
90. E. Kalkhoven, S. Wissink, P.T. van der Saag, and B. van der Burg Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor J Biol Chem 271 11 1996 6217 6224 (Pubitemid 26095429)
91. J.J. Palvimo, P. Reinikainen, T. Ikonen, P.J. Kallio, A. Moilanen, and O.A. Janne Mutual transcriptional interference between RelA and androgen receptor J Biol Chem 271 39 1996 24151 24156 (Pubitemid 26327398)
92. T. Bellido, R.L. Jilka, B.F. Boyce, G. Girasole, H. Broxmeyer, and S.A. Dalrymple Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor J Clin Invest 95 6 1995 2886 2895
93. J. Liden, F. Delaunay, I. Rafter, J. Gustafsson, and S. Okret A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation J Biol Chem 272 34 1997 21467 21472 (Pubitemid 27374019)
94. L.I. McKay, and J.A. Cidlowski Molecular control of immune/inflammatory responses: interactions between nuclear factor-{kappa}B and steroid receptor-signaling pathways Endocr Rev 20 4 1999 435 459 (Pubitemid 30648895)
95. K.W. Nettles, and G.L. Greene Ligand control of coregulator recruitment to nuclear receptors Annu Rev Physiol 67 2005 309 333 (Pubitemid 40404494)
96. N.J. McKenna, R.B. Lanz, and B.W. O'Malley Nuclear receptor coregulators: cellular and molecular biology Endocr Rev 20 3 1999 321 344 (Pubitemid 30649811)
97. C.A. Heinlein, and C. Chang Androgen receptor (AR) coregulators: an overview Endocr Rev 23 2 2002 175 200 (Pubitemid 34299023)
98. C. Stellato Post-transcriptional and nongenomic effects of glucocorticoids Proc Am Thorac Soc 1 3 2004 255 263
99. M.E. Wierman Sex steroid effects at target tissues: mechanisms of action Adv Physiol Educ 31 1 2007 26 33
100. C. Grossmann, and M. Gekle New aspects of rapid aldosterone signaling Mol Cell Endocrinol 308 1-2 2009 53 62
101. Y. Zhu, R. Hanna, M. Schaaf, H. Spaink, and P. Thomas Candidates for membrane progestin receptors - past approaches and future challenges Comp Biochem Physiol C Toxicol Pharmacol 148 4 2008 381 389
102. F. Limbourg, Z. Huang, J. Plumier, T. Simoncini, M. Fujioka, and J. Tuckermann Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids J Clin Invest 110 11 2002 1729 1738 (Pubitemid 35424251)
103. L. Raz, M. Khan, V. Mahesh, R. Vadlamudi, and D. Brann Rapid estrogen signaling in the brain Neurosignals 16 2-3 2008 140 153 (Pubitemid 351263221)
104. W. Walker Nongenomic actions of androgen in Sertoli cells Curr Top Dev Biol 56 2003 25 53 (Pubitemid 137639482)
105. J. Nilsen, and R.D. Brinton Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling Proc Natl Acad Sci USA 100 2003 10506 10511 (Pubitemid 37071908)
106. V. Boonyaratanakornkit, and D.P. Edwards Receptor mechanisms mediating non-genomic actions of sex steroids Semin Reprod Med 25 3 2007 139 153 (Pubitemid 46676901)
107. P. Thomas Characteristics of membrane progestin receptor alpha (mPR[alpha]) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions Front Neuroendocrinol 29 2 2008 292 312
108. P. Thomas, Y. Pang, J. Dong, P. Groenen, J. Kelder, and J. de Vlieg Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor {alpha} subtypes and their evolutionary origins Endocrinology 148 2 2007 705 718 (Pubitemid 46143172)
109. C. Dosiou, A.E. Hamilton, Y. Pang, M.T. Overgaard, S. Tulac, and J. Dong Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone J Endocrinol 196 1 2008 67 77 (Pubitemid 351234572)
110. S. Chen, N.J. Sarlis, and S.S. Simons Jr. Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription J Biol Chem 275 39 2000 30106 30117
111. K. Ronacher, K. Hadley, C. Avenant, E. Stubsrud, S.S. Simons Jr., and A. Louw Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction Mol Cell Endocrinol 299 2 2009 219 231
112. J.C.J.T. Foreman, and A.J. Gibb Textbook of receptor pharmacology 3rd ed. 2010 CRC Press
113. Inc GS. GraphPad Prism Manual Version 5.00; 1992-2007.
114. S.S. Simons Jr. What goes on behind closed doors: physiological versus pharmacological steroid hormone actions Bioessays 30 8 2008 744 756
115. Q. Zhao, J. Pang, M.F. Favata, and J.M. Trzaskos Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression Int Immunopharmacol 3 13-14 2003 1803 1817 (Pubitemid 37421265)
116. G. Hammond Access of reproductive steroids to target tissues Obstet Gynecol Clin North Am 29 3 2002 411 423
117. K.T. Kirton, and J.C. Cornette Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera) Contraception 10 1 1974 39 45
118. K. Fotherby Variability of pharmacokinetic parameters for contraceptive steroids J Steroid Biochem 19 1C 1983 817 820
119. K. Shrimanker, B. Saxena, and K. Fotherby A radioimmunoassay for serum medroxyprogesterone acetate J Steroid Biochem 9 4 1978 359 363 (Pubitemid 8349058)
120. M. Hiroi, F.Z. Stanczyk, U. Goebelsmann, P.F. Brenner, M.E. Lumkin, and D.R. Mishell Jr. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration Steroids 26 3 1975 373 386
121. V. Odlind, E. Weiner, and E.D. Johansson Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone Contraception 19 2 1979 197 206 (Pubitemid 9125597)
122. J. Spona, E. Weiner, B. Nieuweboer, M. Humpel, W.H. Schneider, and E.D. Johansson Injectable depot contraceptives on d-norgestrel basis. II. Clinical pharmacokinetic studies with d-norgestrel undecylate in women Contraception 15 4 1977 413 428 (Pubitemid 8088005)
123. M. Oettel, G. Kaufmann, and A. Kurischko The endocrinologic profile of metabolites of the progestin dienogest Pharmazie 48 7 1993 541 545 (Pubitemid 23258218)
124. H. Blode, W. Wuttke, W. Loock, G. Roll, and R. Heithecker A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers Eur J Contracept Reprod Health Care 5 4 2000 256 264 (Pubitemid 32165464)
125. R. Sitruk-Ware Routes of delivery for progesterone and progestins Maturitas 57 1 2007 77 80 (Pubitemid 46602896)
126. R. Sitruk-Ware Pharmacology of different progestogens: the special case of drospirenone Climacteric 8 Suppl. 3 2005 4 12 (Pubitemid 41608058)
127. R. Sitruk-Ware Contraception: an international perspective Contraception 73 3 2006 215 222 (Pubitemid 43202169)
128. H. Kuhl Pharmacology of estrogens and progestogens: influence of different routes of administration Climacteric 8 Suppl. 1 2005 3 63 (Pubitemid 41232429)
129. N. Kumar, S.S. Koide, Y. Tsong, and K. Sundaram Nestorone: a progestin with a unique pharmacological profile Steroids 65 10-11 2000 629 636
130. B. de Lignieres, and S. Silberstein Pharmacodynamics of oestrogens and progestogens Cephalalgia 20 3 2000 200 207 (Pubitemid 32269509)
131. R.K. Mangal, R.D. Wiehle, A.N. Poindexter III, and N.L. Weigel Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle J Steroid Biochem Mol Biol 63 4-6 1997 195 202 (Pubitemid 28137157)
132. S.M. Soyal, A. Mukherjee, K.Y. Lee, J. Li, H. Li, and F.J. DeMayo Cre-mediated recombination in cell lineages that express the progesterone receptor Genesis 41 2 2005 58 66 (Pubitemid 40365659)
133. O.M. Conneely, B. Mulac-Jericevic, F. DeMayo, J.P. Lydon, and B.W. O'Malley Reproductive Functions of Progesterone Receptors Recent Prog Horm Res 57 1 2002 339 355
134. C.L. Clarke Cell-specific regulation of progesterone receptor in the female reproductive system Mol Cell Endocrinol 70 3 1990 C29 C33
135. J.K. Richer, B.M. Jacobsen, N.G. Manning, M.G. Abel, D.M. Wolf, and K.B. Horwitz Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells J Biol Chem 277 7 2002 5209 5218 (Pubitemid 34968565)
136. J.F. Dunn, B.C. Nisula, and D. Rodbard Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma J Clin Endocrinol Metab 53 1 1981 58 68 (Pubitemid 13245381)
137. M.R. Moore, J.L. Zhou, K.A. Blankenship, J.S. Strobl, D.P. Edwards, and R.N. Gentry A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene J Steroid Biochem Mol Biol 62 4 1997 243 252 (Pubitemid 27504755)
138. G.I. Owen, J.K. Richer, L. Tung, G. Takimoto, and K.B. Horwitz Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300 J Biol Chem 273 1998 10696 10701 (Pubitemid 28227684)
139. C.A. Lange, J.K. Richer, T. Shen, and K.B. Horwitz Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways J Biol Chem 273 47 1998 31308 31316 (Pubitemid 28533147)
140. P. Kastner, M.T. Bocquel, B. Turcotte, J.M. Garnier, K.B. Horwitz, and P. Chambon Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms J Biol Chem 265 21 1990 12163 12167
141. C. Sartorius, M. Melville, A. Hovland, L. Tung, G. Takimoto, and K. Horwitz A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform Mol Endocrinol 8 10 1994 1347 1360 (Pubitemid 24335078)
142. D.X. Wen, Y.F. Xu, D.E. Mais, M.E. Goldman, and D.P. McDonnell The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells Mol Cell Biol 14 12 1994 8356 8364 (Pubitemid 24373584)
143. P.H. Giangrande, E.A. Kimbrel, D.P. Edwards, and D.P. McDonnell The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding Mol Cell Biol 20 9 2000 3102 3115 (Pubitemid 30215023)
144. G. Shyamala, W. Schneider, and D. Schott Developmental regulation of murine mammary progesterone receptor gene expression Endocrinology 126 6 1990 2882 2889 (Pubitemid 20216539)
145. B. Mulac-Jericevic, and O.M. Conneely Reproductive tissue selective actions of progesterone receptors Reproduction 128 2 2004 139 146 (Pubitemid 39162684)
146. E.W. Bergink, F. van Meel, E.W. Turpijn, and J. van der Vies Binding of progestagens to receptor proteins in MCF-7 cells J Steroid Biochem 19 5 1983 1563 1570 (Pubitemid 14205827)
147. P.D. Feil, and C.W. Bardin The use of medroxyprogesterone acetate to study progestin receptors in immature, pregnant, and adult rabbit uterus Adv Exp Med Biol 117 1979 241 254
148. P.J. Selman, J. Wolfswinkel, and J.A. Mol Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog Steroids 61 3 1996 133 137 (Pubitemid 26084147)
149. G.H. Deckers, W.G. Schoonen, and H.J. Kloosterboer Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals J Steroid Biochem Mol Biol 74 3 2000 83 92
150. B.A. Chavez, F. Vilchis, A.E. Perez, G.A. Garcia, I. Grillasca, and G. Perez-Palacios Stereospecificity of the intracellular binding of norethisterone and its A-ring reduced metabolites J Steroid Biochem 22 1 1985 121 126 (Pubitemid 15130268)
151. K. Kontula, O. Janne, R. Vihko, E. de Jager, J. de Visser, and F. Zeelen Progesterone-binding proteins: In vitro binding and biological activity of different steroidal ligands Acta Endocrinol 78 3 1975 574 592
152. U. Fuhrmann, R. Krattenmacher, E.P. Slater, and K.H. Fritzemeier The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential Contraception 54 4 1996 243 251 (Pubitemid 26398621)
153. R. Krattenmacher Drospirenone: pharmacology and pharmacokinetics of a unique progestogen Contraception 62 2000 29 38
154. H.J. Kloosterboer, C.A. Vonk-Noordegraaf, and E.W. Turpijn Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives Contraception 38 3 1988 325 332
155. W.G.E.J. Schoonen, R. Dijkema, R.J.H. de Ries, J.L. Wagenaars, J.W.H. Joosten, and M.E. de Gooyer Human progesterone receptor A and B isoforms in CHO cells. II. Comparison of binding, transactivation and ed50 values of several synthetic (anti)progestagens in vitro in CHO and MCF-7 cells and in vivo in rabbits and rats J Steroid Biochem Mol Biol 64 3-4 1998 157 170 (Pubitemid 28200988)
156. O.M. Conneely Perspective: female steroid hormone action Endocrinology 142 6 2001 2194 2199 (Pubitemid 32473071)
157. R. Ghatge, B. Jacobsen, S. Schittone, and K. Horwitz The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells Breast Cancer Res 7 6 2005 R1036 R1050
158. S.M. Hyder, L. Murthy, and G.M. Stancel Progestin regulation of vascular endothelial growth factor in human breast cancer cells Cancer Res 58 3 1998 392 395 (Pubitemid 28087395)
159. J.D. Bray, S. Jelinsky, R. Ghatge, J.A. Bray, C. Tunkey, and K. Saraf Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells J Steroid Biochem Mol Biol 97 4 2005 328 341 (Pubitemid 41619412)
160. M. Saitoh, M. Ohmichi, K. Takahashi, J. Kawagoe, T. Ohta, and M. Doshida Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells Endocrinology 146 11 2005 4917 4925 (Pubitemid 41446630)
161. D. Zhao, D.I. Lebovic, and R.N. Taylor Long-term progestin treatment inhibits RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) gene expression in human endometrial stromal cells J Clin Endocrinol Metab 87 6 2002 2514 2519 (Pubitemid 34655307)
162. R. Ramhorst, R. Patel, A. Corigliano, J. Etchepareborda, L. Fainboim, and D. Schust Induction of maternal tolerance to fetal alloantigens by RANTES production Am J Reprod Immunol 56 5-6 2006 302 311 (Pubitemid 44669326)
163. H. Tatsumi, J. Kitawaki, K. Tanaka, T. Hosoda, and H. Honjo Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins Maturitas 42 4 2002 287 294 (Pubitemid 35007322)
164. T. Simoncini, P. Mannella, L. Fornari, A. Caruso, M.Y. Willis, and S. Garibaldi Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells Endocrinology 145 12 2004 5745 5756 (Pubitemid 39564616)
165. T. Simoncini, P. Mannella, N. Pluchino, and A. Genazzani Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels Gynecol Endocrinol 23 Suppl. 1 2007 9 16 (Pubitemid 47613712)
166. M. Yasa, and S. Turkseven Vasoprotective effects of nitric oxide in atherosclerosis FABAD J Pharm Sci 30 1 2005 41 53
167. M.D. Mueller, J.L. Vigne, E.A. Pritts, V. Chao, E. Dreher, and R.N. Taylor Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells Fertil Steril 79 2 2003 386 392 (Pubitemid 36144065)
168. V. Boonyaratanakornk, Y. Bi, M. Rudd, and D. Edwards The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression Steroids 73 9-10 2008 922 928
169. X.D. Fu, M.S. Giretti, L. Goglia, M.I. Flamini, A.M. Sanchez, and C. Baldacci Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion BMC Cancer 8 2008 166
170. R.H. Oakley, and J.A. Cidlowski Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids J Biol Chem 286 5 2011 3177 3184
171. D. Koubovec, K. Ronacher, E. Stubsrud, A. Louw, and J.P. Hapgood Synthetic progestins used in HRT have different glucocorticoid agonist properties Mol Cell Endocrinol 242 1-2 2005 23 32 (Pubitemid 41393707)
172. F.A. Teulings, H.A. van Gilse, M.S. Henkelman, H. Portengen, and J. Alexieva-Figusch Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer Cancer Res 40 1980 2557 2561 (Pubitemid 10082284)
173. K. Kontula, T. Paavonen, T. Luukkainen, and L.C. Andersson Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes Biochem Pharmacol 32 9 1983 1511 1518 (Pubitemid 13096010)
174. U. Fuhrmann, E.P. Slater, and K.H. Fritzemeier Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays Contraception 51 1 1995 45 52
175. W.G. Schoonen, G.H. Deckers, M.E. de Gooijer, R. de Ries, and H.J. Kloosterboer Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives J Steroid Biochem Mol Biol 74 4 2000 213 222 (Pubitemid 32121657)
176. E. Charmandari, D.R. Matthews, A. Johnston, C.G.D. Brook, and P.C. Hindmarsh Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab 86 10 2001 4679 4685 (Pubitemid 33020506)
177. E. Imai, J.N. Miner, J.A. Mitchell, K.R. Yamamoto, and D.K. Granner Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids J Biol Chem 268 8 1993 5353 5356 (Pubitemid 23090847)
178. A.R. Brasier, and J. Li Mechanisms for inducible control of angiotensinogen gene transcription Hypertension 27 3 1996 465 475 (Pubitemid 26086217)
179. B.L. Spangelo, and W.C. Gorospe Role of the cytokines in the neuroendocrine-immune system axis Front Neuroendocrinol 16 1 1995 1 22
180. J. Galon, D. Franchimont, N. Hiroi, G. Frey, A. Boettner, and M. Ehrhart-Bornstein Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells FASEB J 16 1 2002 61 71 (Pubitemid 34027951)
181. C.P. Thomas, K.Z. Liu, and H.S. Vats Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate alpha-ENaC and sgk1 expression in renal collecting duct epithelia Am J Physiol Renal Physiol 290 2 2006 F306 F312
182. O. Herkert, H. Kuhl, J. Sandow, R. Busse, and V.B. Schini-Kerth Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor Circulation 104 23 2001 2826 2831 (Pubitemid 33126658)
183. T. Ouatas, D. Halverson, and P.S. Steeg Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds Clin Cancer Res 9 10 Pt 1 2003 3763 3772 (Pubitemid 37169246)
184. M. Zerr-Fouineau, M. Chataigneau, C. Blot, and V.B. Schini-Kerth Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors FASEB J 21 1 2007 265 273 (Pubitemid 46052565)
185. J. Donath, H. Michna, and Y. Nishino The antiovulatory effect of the antiprogestin onapristone could be related to down-regulation of intraovarian progesterone (receptors) J Steroid Biochem Mol Biol 62 1 1997 107 118 (Pubitemid 27462755)
186. Z. Liao, T.W.-M. Boileau, J.W. Erdman Jr., and S.K. Clinton Interrelationships among angiogenesis, proliferation, and apoptosis in the tumor microenvironment during N-methyl-N-nitrosourea androgen-induced prostate carcinogenesis in rats Carcinogenesis 23 10 2002 1701 1712
187. K.A. Walters, K.J. McTavish, M.G. Seneviratne, M. Jimenez, A.C. McMahon, and C.M. Allan Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function Endocrinology 150 7 2009 3274 3282
188. G. Goodman Managing acne vulgaris effectively Aust Fam Phys 35 9 2006 705 709
189. J.A. Kemppainen, E. Langley, C.I. Wong, K. Bobseine, W.R. Kelce, and E.M. Wilson Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone Mol Endocrinol 13 3 1999 440 454 (Pubitemid 29113876)
190. G. Perez-Palacios, B. Chavez, N. Escobar, F. Vilchis, F. Larrea, and M. Lince Mechanism of action of contraceptive synthetic progestins J Steroid Biochem 15 1981 125 130 (Pubitemid 12069230)
191. R. Hackenberg, T. Hawighorst, A. Filmer, A.H. Nia, and K.D. Schulz Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor Breast Cancer Res Treat 25 3 1993 217 224 (Pubitemid 23198726)
192. J.M. Bentel, S.N. Birrell, M.A. Pickering, D.J. Holds, D.J. Horsfall, and W.D. Tilley Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells Mol Cell Endocrinol 154 1-2 1999 11 20 (Pubitemid 29387325)
193. S. Lello Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy Drugs 70 5 2010 541 559
194. van Diepen HA, Lam TW, Kuil CW. Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey. Contraception 2011; In Press, doi:10.1016/j.contraception. 2010.11.017.
195. K. Fotherby Interactions with oral contraceptives Am J Obstet Gynecol 163 6 Pt 2 1990 2153 2159
196. H. Schneider Androgens and antiandrogens Ann N Y Acad Sci 997 2003 292 306 (Pubitemid 38491085)
197. R. Garcia-Becerra, A.J. Cooney, E. Borja-Cacho, A.E. Lemus, G. Perez-Palacios, and F. Larrea Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone- derived progestins J Steroid Biochem Mol Biol 91 1-2 2004 21 27 (Pubitemid 38903180)
198. S.N. Birrell, L.M. Butler, J.M. Harris, G. Buchanan, and W.D. Tilley Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer FASEB J 21 10 2007 2285 2293 (Pubitemid 47230658)
199. F. Labrie, L. Cusan, J. Gomez, V. Luu-The, B. Candas, and A. Belanger Major impact of hormonal therapy in localized prostate cancer - death can already be an exception J Steroid Biochem Mol Biol 92 5 2004 327 344 (Pubitemid 40187151)
200. Z.S. Krozowski, and J.W. Funder Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity Proc Natl Acad Sci USA 80 19 1983 6056 6060 (Pubitemid 14228243)
201. E.R. de Kloet, S.A. Van Acker, R.M. Sibug, M.S. Oitzl, O.C. Meijer, and K. Rahmouni Brain mineralocorticoid receptors and centrally regulated functions Kidney Int 57 4 2000 1329 1336 (Pubitemid 30207887)
202. J.W. Funder Aldosterone, mineralocorticoid receptors and vascular inflammation Mol Cell Endocrinol 217 1-2 2004 263 269 (Pubitemid 38596652)
203. G. Wambach, J.R. Higgins, D.C. Kem, and W. Kaufmann Interaction of synthetic progestagens with renal mineralocorticoid receptors Acta Endocrinol (Copenh) 92 3 1979 560 567 (Pubitemid 10160855)
204. M.E. Rafestin-Oblin, M. Lombes, B. Couette, and E.E. Baulieu Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor J Steroid Biochem Mol Biol 41 3-8 1992 815 821
205. M. Quinkler, and S. Diederich Difference of in vivo and in vitro antimineralocorticoid potency of progesterone Endocr Res 28 4 2002 465 470 (Pubitemid 36042502)
206. M. Quinkler, B. Meyer, C. Bumke-Vogt, C. Grossmann, U. Gruber, and W. Oelkers Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor Eur J Endocrinol 146 6 2002 789 799
207. W.K. Oelkers Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure Steroids 61 4 1996 166 171 (Pubitemid 26146736)
208. P.B. Rylance, M. Brincat, K. Lafferty, J.C. De Trafford, S. Brincat, and V. Parsons Natural progesterone and antihypertensive action Br Med J (Clin Res Ed) 290 6461 1985 13 14 (Pubitemid 15075974)
209. A. Genazzani, M. Gambacciani, T. Simoncini, R. Anniverno, A.M. Becorpi, and N. Biglia Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007 Gynecol Endocrinol 23 8 2007 436 444 (Pubitemid 47575055)
210. S. Palacios, J.M. Foidart, and A.R. Genazzani Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism Maturitas 55 4 2006 297 307 (Pubitemid 44767795)
211. H. Seeger, D. Wallwiener, and A.O. Mueck Effects of drospirenone on cardiovascular markers in human aortic endothelial cells Climacteric 12 1 2009 80 87
212. R.D. Zipser, V. Meidar, and R. Horton Characteristics of aldosterone binding in human plasma J Clin Endocrinol Metab 50 1 1980 158 162 (Pubitemid 10203594)
213. G.M. Rosano, G. Mercuro, C. Vitale, P. Rossini, P. Galetta, and M. Fini How progestins influence the cardiovascular effect of hormone replacement therapy Gynecol Endocrinol 15 Suppl. 6 2001 9 17 (Pubitemid 33731346)
214. P.A. Arias-Loza, M. Muehlfelder, S.A. Elmore, R. Maronpot, K. Hu, and H. Blode Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease Toxicol Pathol 37 7 2009 969 982
215. W. Oelkers Drospirenone in combination with estrogens: for contraception and hormone replacement therapy Climacteric 8 Suppl. 3 2005 19 27 (Pubitemid 41608060)
216. T.A. Grese, and J.A. Dodge Selective estrogen receptor modulators (SERMs) Curr Pharm Des 4 1 1998 71 92 (Pubitemid 28090069)
217. F. Di Carlo, E. Gallo, G. Conti, and S. Racca Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives J Endocrinol 98 3 1983 385 389 (Pubitemid 13020958)
218. L. Markiewicz, and E. Gurpide Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells J Steroid Biochem Mol Biol 48 1 1994 89 94 (Pubitemid 24123074)
219. C.A. Mendoza-Rodriguez, I. Camacho-Arroyo, G.A. Garcia, and M.A. Cerbon Variations of progesterone receptor and c-fos gene expression in the rat uterus after treatment with norethisterone and its A-ring reduced metabolites Contraception 59 5 1999 339 343 (Pubitemid 29406036)
220. F. Larrea, R. Garcia-Becerra, A.E. Lemus, G.A. Garcia, G. Perez-Palacios, and K.J. Jackson A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha Endocrinology 142 9 2001 3791 3799 (Pubitemid 32807699)
221. M. Genesca, M.B. McChesney, and C.J. Miller Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus PLoS One 5 3 2010 e9814
222. ®): a highly effective contraceptive option with proven long-term safety Contraception 68 2 2003 75 87 (Pubitemid 37101031)
223. M. Elovitz, and Z. Wang Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise Am J Obstet Gynecol 190 3 2004 693 701 (Pubitemid 38406780)
224. C.S. Morrison, P.-L. Chen, C. Kwok, B.A. Richardson, T. Chipato, and R. Mugerwa Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling AIDS 24 11 2010 1778 1781 10.097/QAD.0b013e32833a2537
225. K. Gross, and J. Cidlowski Tissue-specific glucocorticoid action: a family affair Trends Endocrinol Metab 19 9 2008 331 339